Terms: = Liver cancer AND CEACAM5, CEA AND Treatment
774 results:
1. Single-cell analysis revealed a potential role of T-cell exhaustion in colorectal cancer with liver metastasis.
Ling T; Zhang C; Liu Y; Jiang C; Gu L
J Cell Mol Med; 2024 Apr; 28(8):e18341. PubMed ID: 38647235
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis.
Tian Y; Wang Y; Wen N; Wang S; Li B; Liu G
BMC Cancer; 2024 Apr; 24(1):426. PubMed ID: 38584263
[TBL] [Abstract] [Full Text] [Related]
3. Clinical study on simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy for synchronous colorectal cancer liver metastasis.
Li W; Ren H; Mou H; Li J; Dong L; Li G; Xing M
J Gastrointest Surg; 2024 Apr; 28(4):425-433. PubMed ID: 38583892
[TBL] [Abstract] [Full Text] [Related]
4. Initial presentation of hepatocellular carcinoma as pharyngeal mass mimicking advanced hypopharyngeal carcinoma.
Sukumaran R; Kattoor J; Valsalamony J; Varghese BT
J Cancer Res Ther; 2024 Jan; 20(1):438-440. PubMed ID: 38554358
[TBL] [Abstract] [Full Text] [Related]
5. Predictive nomograms of repeat intrahepatic recurrence and overall survival after radiofrequency ablation of recurrent colorectal liver metastases.
Wang JC; Jiang BB; Zhang ZY; Liu YH; Shao LJ; Wang S; Yang W; Wu W; Yan K
Int J Hyperthermia; 2024; 41(1):2323152. PubMed ID: 38465646
[TBL] [Abstract] [Full Text] [Related]
6. Development and validation of comprehensive nomograms from the SEER database for predicting early mortality in metastatic rectal cancer patients.
Li Y; Tao T; Liu Y
BMC Gastroenterol; 2024 Feb; 24(1):89. PubMed ID: 38408896
[TBL] [Abstract] [Full Text] [Related]
7. Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNIcancer, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR).
Lecomte T; Tougeron D; Chautard R; Bressand D; Bibeau F; Blanc B; Cohen R; Jacques J; Lagasse JP; Laurent-Puig P; Lepage C; Lucidarme O; Martin-Babau J; Panis Y; Portales F; Taieb J; Aparicio T; Bouché O; ; ; ; ; ; ; ; ; ; ; ;
Dig Liver Dis; 2024 May; 56(5):756-769. PubMed ID: 38383162
[TBL] [Abstract] [Full Text] [Related]
8. [liver transplantation for treatment of nonresectable primary and secondary liver malignancies : Hepatocellular and cholangiocellular carcinomas and colorectal liver metastases].
Guba M; Werner J
Chirurgie (Heidelb); 2024 Apr; 95(4):268-273. PubMed ID: 38329517
[TBL] [Abstract] [Full Text] [Related]
9. Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors.
Peters S; Angevin E; Alonso-Gordoa T; Rohrberg K; Melero I; Mellado B; Perez-Gracia JL; Tabernero J; Adessi C; Boetsch C; Watson C; Dal Porto J; Dejardin D; Del Nagro C; Nicolini V; Evers S; Klein C; Leutgeb B; Pisa P; Rossmann E; Saro J; Umana P; Charo J; Teichgräber V; Steeghs N
Clin Cancer Res; 2024 Apr; 30(8):1630-1641. PubMed ID: 38319672
[TBL] [Abstract] [Full Text] [Related]
10. [A Case of Long-Term Survival with Metachronous Hepatic and Pulmonary Metastases from Transverse Colon cancer by Multidisciplinary treatment].
Hara T; Okano M; Hata T; Takayama O; Kim Y; Imamoto H; Hasegawa J
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1857-1859. PubMed ID: 38303231
[TBL] [Abstract] [Full Text] [Related]
11. Immunotherapy in mismatch repair-deficient metastatic colorectal cancer - Outcome and novel predictive markers.
Stemmer A; Margalit O; Serpas V; Strauss G; Thomas J; Shah P; Tau N; Levanon K; Shacham-Shmueli E; Kopetz S; Overman M; Boursi B
Eur J Cancer; 2024 Feb; 198():113495. PubMed ID: 38157568
[TBL] [Abstract] [Full Text] [Related]
12. Diagnosis and treatment of hepatic cysts. Usefulness of intracystic tumor markers (cea and CA 19.9.).
Polette D; Mils K; López-Domínguez F; Barrios O; Leiva D; Puig I; Ramos E; Lladó L
Cir Esp (Engl Ed); 2024 Jan; 102(1):19-24. PubMed ID: 37980963
[TBL] [Abstract] [Full Text] [Related]
13. Prediction of liver and lung metastases in patients with early-onset colorectal cancer by nomograms based on heterogeneous and homogenous risk factors.
E Y; Sun S; Fan X; Lu C; Ji P; Huang Y; Sun J; Yang X; Yu C
Cancer Med; 2023 Nov; 12(22):20712-20726. PubMed ID: 37902182
[TBL] [Abstract] [Full Text] [Related]
14. The Leser-Trélat Sign in a Patient with Gastric Adenocarcinoma.
Geber A; Hadžavdić A; Ljubojević Hadžavdić S
Acta Dermatovenerol Croat; 2023 Aug; 31(1):51-52. PubMed ID: 37843094
[TBL] [Abstract] [Full Text] [Related]
15. Aldolase B-driven lactagenesis and ceaCAM6 activation promote cell renewal and chemoresistance in colorectal cancer through the Warburg effect.
Chu YD; Cheng LC; Lim SN; Lai MW; Yeh CT; Lin WR
Cell Death Dis; 2023 Oct; 14(10):660. PubMed ID: 37816733
[TBL] [Abstract] [Full Text] [Related]
16. Prediction model of ocular metastasis from primary liver cancer: Machine learning-based development and interpretation study.
Sun JQ; Wu SN; Mou ZL; Wen JY; Wei H; Zou J; Li QJ; Liu ZL; Xu SH; Kang M; Ling Q; Huang H; Chen X; Wang YX; Liao XL; Tan G; Shao Y
Cancer Med; 2023 Oct; 12(20):20482-20496. PubMed ID: 37795569
[TBL] [Abstract] [Full Text] [Related]
17. Role of CA 19.9 and cea in predicting diagnosis in hepatocellular carcinoma.
Verma N; Vinocha A
J Cancer Res Ther; 2023; 19(5):1356-1358. PubMed ID: 37787308
[TBL] [Abstract] [Full Text] [Related]
18. Increased Incidence of liver Metastases in Colorectal
Garrett C; Cristaudo A; Barat S; Morris DL
Anticancer Res; 2023 Oct; 43(10):4657-4662. PubMed ID: 37772565
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of prognostic factors in different grades of histologic differentiation in colorectal cancer patients receiving preoperative neoadjuvant chemotherapy and establishment of prognostic nomograms for moderately differentiated grade.
Luo X; E Y; Wu J; Lu C; Zhang J
Int J Colorectal Dis; 2023 Sep; 38(1):237. PubMed ID: 37747505
[TBL] [Abstract] [Full Text] [Related]
20. An autopsy case of alpha-fetoprotein-producing large duodenal adenocarcinoma.
Hirota S; Naganuma A; Kobayashi R; Suzuki Y; Hoshino T; Yasuoka H; Tanaka Y; Uraoka T; Kakizaki S
Clin J Gastroenterol; 2023 Dec; 16(6):829-835. PubMed ID: 37594614
[TBL] [Abstract] [Full Text] [Related]
[Next]
